Literature DB >> 27789795

Epigenetic stability of exhausted T cells limits durability of reinvigoration by PD-1 blockade.

Kristen E Pauken1, Morgan A Sammons2, Pamela M Odorizzi1, Sasikanth Manne1, Jernej Godec3,4, Omar Khan1, Adam M Drake2, Zeyu Chen1, Debattama R Sen3, Makoto Kurachi1, R Anthony Barnitz3, Caroline Bartman1, Bertram Bengsch1, Alexander C Huang5, Jason M Schenkel6, Golnaz Vahedi7, W Nicholas Haining3,8,9, Shelley L Berger2, E John Wherry10.   

Abstract

Blocking Programmed Death-1 (PD-1) can reinvigorate exhausted CD8 T cells (TEX) and improve control of chronic infections and cancer. However, whether blocking PD-1 can reprogram TEX into durable memory T cells (TMEM) is unclear. We found that reinvigoration of TEX in mice by PD-L1 blockade caused minimal memory development. After blockade, reinvigorated TEX became reexhausted if antigen concentration remained high and failed to become TMEM upon antigen clearance. TEX acquired an epigenetic profile distinct from that of effector T cells (TEFF) and TMEM cells that was minimally remodeled after PD-L1 blockade. This finding suggests that TEX are a distinct lineage of CD8 T cells. Nevertheless, PD-1 pathway blockade resulted in transcriptional rewiring and reengagement of effector circuitry in the TEX epigenetic landscape. These data indicate that epigenetic fate inflexibility may limit current immunotherapies.
Copyright © 2016, American Association for the Advancement of Science.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27789795      PMCID: PMC5484795          DOI: 10.1126/science.aaf2807

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  30 in total

1.  Chronic virus infection enforces demethylation of the locus that encodes PD-1 in antigen-specific CD8(+) T cells.

Authors:  Ben Youngblood; Kenneth J Oestreich; Sang-Jun Ha; Jaikumar Duraiswamy; Rama S Akondy; Erin E West; Zhengyu Wei; Peiyuan Lu; James W Austin; James L Riley; Jeremy M Boss; Rafi Ahmed
Journal:  Immunity       Date:  2011-09-23       Impact factor: 31.745

Review 2.  The future of immune checkpoint therapy.

Authors:  Padmanee Sharma; James P Allison
Journal:  Science       Date:  2015-04-03       Impact factor: 47.728

3.  Progressive loss of memory T cell potential and commitment to exhaustion during chronic viral infection.

Authors:  Jill M Angelosanto; Shawn D Blackburn; Alison Crawford; E John Wherry
Journal:  J Virol       Date:  2012-05-23       Impact factor: 5.103

4.  Selective effects of PD-1 on Akt and Ras pathways regulate molecular components of the cell cycle and inhibit T cell proliferation.

Authors:  Nikolaos Patsoukis; Julia Brown; Victoria Petkova; Fang Liu; Lequn Li; Vassiliki A Boussiotis
Journal:  Sci Signal       Date:  2012-06-26       Impact factor: 8.192

5.  The transcription factor NFAT promotes exhaustion of activated CD8⁺ T cells.

Authors:  Gustavo J Martinez; Renata M Pereira; Tarmo Äijö; Edward Y Kim; Francesco Marangoni; Matthew E Pipkin; Susan Togher; Vigo Heissmeyer; Yi Chen Zhang; Shane Crotty; Edward D Lamperti; K Mark Ansel; Thorsten R Mempel; Harri Lähdesmäki; Patrick G Hogan; Anjana Rao
Journal:  Immunity       Date:  2015-02-10       Impact factor: 31.745

6.  IL-7 engages multiple mechanisms to overcome chronic viral infection and limit organ pathology.

Authors:  Marc Pellegrini; Thomas Calzascia; Jesse G Toe; Simon P Preston; Amy E Lin; Alisha R Elford; Arda Shahinian; Philipp A Lang; Karl S Lang; Michel Morre; Brigitte Assouline; Katharina Lahl; Tim Sparwasser; Thomas F Tedder; Ji-Hye Paik; Ronald A DePinho; Sameh Basta; Pamela S Ohashi; Tak W Mak
Journal:  Cell       Date:  2011-02-03       Impact factor: 41.582

7.  The transcription factor FoxO1 sustains expression of the inhibitory receptor PD-1 and survival of antiviral CD8(+) T cells during chronic infection.

Authors:  Matthew M Staron; Simon M Gray; Heather D Marshall; Ian A Parish; Jonathan H Chen; Curtis J Perry; Guoliang Cui; Ming O Li; Susan M Kaech
Journal:  Immunity       Date:  2014-11-13       Impact factor: 31.745

Review 8.  The TNF Receptor Superfamily in Co-stimulating and Co-inhibitory Responses.

Authors:  Lindsay K Ward-Kavanagh; Wai Wai Lin; John R Šedý; Carl F Ware
Journal:  Immunity       Date:  2016-05-17       Impact factor: 31.745

9.  Compendium of Immune Signatures Identifies Conserved and Species-Specific Biology in Response to Inflammation.

Authors:  Jernej Godec; Yan Tan; Arthur Liberzon; Pablo Tamayo; Sanchita Bhattacharya; Atul J Butte; Jill P Mesirov; W Nicholas Haining
Journal:  Immunity       Date:  2016-01-12       Impact factor: 31.745

10.  Progenitor and terminal subsets of CD8+ T cells cooperate to contain chronic viral infection.

Authors:  Michael A Paley; Daniela C Kroy; Pamela M Odorizzi; Jonathan B Johnnidis; Douglas V Dolfi; Burton E Barnett; Elizabeth K Bikoff; Elizabeth J Robertson; Georg M Lauer; Steven L Reiner; E John Wherry
Journal:  Science       Date:  2012-11-30       Impact factor: 47.728

View more
  381 in total

Review 1.  Inhibitors of the PD-1 Pathway in Tumor Therapy.

Authors:  Martin W LaFleur; Yuki Muroyama; Charles G Drake; Arlene H Sharpe
Journal:  J Immunol       Date:  2018-01-15       Impact factor: 5.422

Review 2.  Atezolizumab for the treatment of non-small cell lung cancer.

Authors:  Fernando C Santini; Charles M Rudin
Journal:  Expert Rev Clin Pharmacol       Date:  2017-07-27       Impact factor: 5.045

3.  Epigenetic Regulation in Breast Cancer.

Authors:  Hye Jin Nam; Sung Hee Baek
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 4.  Metabolic and Epigenetic Coordination of T Cell and Macrophage Immunity.

Authors:  Anthony T Phan; Ananda W Goldrath; Christopher K Glass
Journal:  Immunity       Date:  2017-05-16       Impact factor: 31.745

5.  Schistosomiasis Induces Persistent DNA Methylation and Tuberculosis-Specific Immune Changes.

Authors:  Andrew R DiNardo; Tomoki Nishiguchi; Emily M Mace; Kimal Rajapakshe; Godwin Mtetwa; Alexander Kay; Gugu Maphalala; W Evan Secor; Rojelio Mejia; Jordan S Orange; Cristian Coarfa; Kapil N Bhalla; Edward A Graviss; Anna M Mandalakas; George Makedonas
Journal:  J Immunol       Date:  2018-05-11       Impact factor: 5.422

6.  Epigenetic Remodeling in Exhausted T Cells: Implications for Transplantation Tolerance.

Authors:  Sonia J Laurie; Mandy L Ford
Journal:  Transplantation       Date:  2017-05       Impact factor: 4.939

7.  Massively parallel single-cell chromatin landscapes of human immune cell development and intratumoral T cell exhaustion.

Authors:  Ansuman T Satpathy; Jeffrey M Granja; Kathryn E Yost; Yanyan Qi; Francesca Meschi; Geoffrey P McDermott; Brett N Olsen; Maxwell R Mumbach; Sarah E Pierce; M Ryan Corces; Preyas Shah; Jason C Bell; Darisha Jhutty; Corey M Nemec; Jean Wang; Li Wang; Yifeng Yin; Paul G Giresi; Anne Lynn S Chang; Grace X Y Zheng; William J Greenleaf; Howard Y Chang
Journal:  Nat Biotechnol       Date:  2019-08-02       Impact factor: 54.908

8.  Leukemia cell-derived microvesicles induce T cell exhaustion via miRNA delivery.

Authors:  Jieke Cui; Qing Li; Mei Luo; Zhaodong Zhong; Shu Zhou; Lin Jiang; Na Shen; Zhe Geng; Hui Cheng; Li Meng; Shujuan Yi; Hui Sun; Feifei Wu; Zunmin Zhu; Ping Zou; Yong You; An-Yuan Guo; Xiaojian Zhu
Journal:  Oncoimmunology       Date:  2018-03-26       Impact factor: 8.110

Review 9.  Epigenetic mechanisms of tumor resistance to immunotherapy.

Authors:  Natalia Arenas-Ramirez; Dilara Sahin; Onur Boyman
Journal:  Cell Mol Life Sci       Date:  2018-08-23       Impact factor: 9.261

10.  Early precursor T cells establish and propagate T cell exhaustion in chronic infection.

Authors:  Daniel T Utzschneider; Sarah S Gabriel; David Chisanga; Renee Gloury; Patrick M Gubser; Ajithkumar Vasanthakumar; Wei Shi; Axel Kallies
Journal:  Nat Immunol       Date:  2020-08-24       Impact factor: 25.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.